Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Net Income - Minority (2022 - 2023)

Zentalis Pharmaceuticals (ZNTL) has 2 years of Net Income - Minority data on record, last reported at -$107000.0 in Q4 2023.

  • For Q4 2023, Net Income - Minority rose 51.58% year-over-year to -$107000.0; the TTM value through Dec 2023 reached -$107000.0, up 51.58%, while the annual FY2023 figure was -$107000.0, 51.58% up from the prior year.
  • Net Income - Minority reached -$107000.0 in Q4 2023 per ZNTL's latest filing, up from -$129000.0 in the prior quarter.
  • Across five years, Net Income - Minority topped out at -$107000.0 in Q4 2023 and bottomed at -$221000.0 in Q4 2022.